{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:42:36Z","timestamp":1782236556268,"version":"3.54.5"},"reference-count":52,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,4,1]]},"DOI":"10.5551\/jat.65214","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T22:10:22Z","timestamp":1729548622000},"page":"513-524","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China"],"prefix":"10.5551","volume":"32","author":[{"given":"Ping-ting","family":"Yang","sequence":"first","affiliation":[{"name":"Health Management Medical Center, The Third Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[{"name":"Shaoxing Second Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-rong","family":"Guo","sequence":"additional","affiliation":[{"name":"Health Management Center, Changji Branch of The First Affiliated Hospital, Xinjiang Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-mei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Health Management, Aerospace Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-xiang","family":"Qin","sequence":"additional","affiliation":[{"name":"Health Management Medical Center, The Third Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of General Practice CThe Third Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-xin","family":"Li","sequence":"additional","affiliation":[{"name":"Xiangya School of Medicine, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-zhang","family":"Guo","sequence":"additional","affiliation":[{"name":"Health Management Center, First Affiliated Hospital of Jishou University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-gang","family":"Wang","sequence":"additional","affiliation":[{"name":"Health Management Medical Center, The Third Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Patel AP, Wang M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S and Khera AV: Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank. Arterioscler Thromb Vasc Biol, 2021; 41: 465-474","DOI":"10.1161\/ATVBAHA.120.315291"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Emerging Risk Factors C, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG and Danesh J: Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA, 2009; 302: 412-423","DOI":"10.1001\/jama.2009.1063"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Gao G, Zheng T, Lan B, Hui W, Chen S, Yuan Z, Wu Y, Chiang JYL and Chen T: Effect of in-hospital evolocumab therapy on lipoprotein(a) in patients with acute myocardial infarction: a retrospective cohort study and a propensity score matching analysis. Cardiology Plus, 2023; 8: 46-52","DOI":"10.1097\/CP9.0000000000000036"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kamstrup PR, Tybjaerg-Hansen A and Nordestgaard BG: Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol, 2014; 63: 470-477","DOI":"10.1016\/j.jacc.2013.09.038"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Arsenault BJ, Boekholdt SM, Dube MP, Rheaume E, Wareham NJ, Khaw KT, Sandhu MS and Tardif JC: Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort. Circ Cardiovasc Genet, 2014; 7: 304-310","DOI":"10.1161\/CIRCGENETICS.113.000400"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) O\u2019Donoghue ML, Fazio S, Giugliano RP, Stroes ESG, Kanevsky E, Gouni-Berthold I, Im K, Lira Pineda A, Wasserman SM, Ceska R, Ezhov MV, Jukema JW, Jensen HK, Tokgozoglu SL, Mach F, Huber K, Sever PS, Keech AC, Pedersen TR and Sabatine MS: Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk. Circulation, 2019; 139: 1483-1492","DOI":"10.1161\/CIRCULATIONAHA.118.037184"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgozoglu L, Tybjaerg-Hansen A and European Atherosclerosis Society Consensus P: Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J, 2010; 31: 2844-2853","DOI":"10.1093\/eurheartj\/ehq386"},{"key":"8","unstructured":"8) Authors\/Task Force M, Guidelines ESCCfP and Societies ESCNC: 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 2019; 290: 140-205"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, Francis GA, Genest J, Gregoire J, Grover SA, Gupta M, Hegele RA, Lau D, Leiter LA, Leung AA, Lonn E, Mancini GBJ, Manjoo P, McPherson R, Ngui D, Piche ME, Poirier P, Sievenpiper J, Stone J, Ward R and Wray W: 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults. Can J Cardiol, 2021; 37: 1129-1150","DOI":"10.1016\/j.cjca.2021.03.016"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokgozoglu LS and Catapano AL: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J, 2022; 43: 3925-3946","DOI":"10.1093\/eurheartj\/ehac361"},{"key":"11","unstructured":"11) Management JCotCGfL: Chinese Guidelines for Lipid Management (2023). Chinese Circulation Journal, 2023; 38: 237-271"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Panza GA, Blazek O, Tortora J, Saucier S and Fernandez AB: Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease. J Clin Lipidol, 2023; 17: 748-755","DOI":"10.1016\/j.jacl.2023.09.016"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Wilkinson MJ, Ma GS, Yeang C, Ang L, Strachan M, DeMaria AN, Tsimikas S and Cotter B: The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting. Angiology, 2017; 68: 795-798","DOI":"10.1177\/0003319716688415"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Krittanawong C, Maitra NS, El-Sherbini AH, Shah N, Lavie CJ, Shapiro MD and Virani SS: Lipoprotein(a) in clinical practice: A guide for the clinician. Prog Cardiovasc Dis, 2023; 79: 28-36","DOI":"10.1016\/j.pcad.2023.07.006"},{"key":"15","unstructured":"15) Yang H: Expert consensus on some problems of cerebral and carotid vascular ultrasonography (Part of carotid). Chin J Cerebrovasc Dis, 2020; 17: 346-353"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Wang X, Li W, Song F, Wang L, Fu Q, Cao S, Gan Y, Zhang W, Yue W, Yan F, Shi W, Wang X, Zhang H, Zhang H, Wang Z and Lu Z: Carotid Atherosclerosis Detected by Ultrasonography: A National Cross-Sectional Study. J Am Heart Assoc, 2018; 7:","DOI":"10.1161\/JAHA.118.008701"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Lu Y, Pechlaner R, Cai J, Yuan H, Huang Z, Yang G, Wang J, Chen Z, Kiechl S and Xu Q: Trajectories of Age-Related Arterial Stiffness in Chinese Men and Women. J Am Coll Cardiol, 2020; 75: 870-880","DOI":"10.1016\/j.jacc.2019.12.039"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tanaka A, Tomiyama H, Maruhashi T, Matsuzawa Y, Miyoshi T, Kabutoya T, Kario K, Sugiyama S, Munakata M, Ito H, Ueda S, Vlachopoulos C, Higashi Y, Inoue T, Node K and Physiological Diagnosis Criteria for Vascular Failure C: Physiological Diagnostic Criteria for Vascular Failure. Hypertension, 2018; 72: 1060-1071","DOI":"10.1161\/HYPERTENSIONAHA.118.11554"},{"key":"19","unstructured":"19) Joint Committee for Guideline R: 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol, 2019; 16: 182-241"},{"key":"20","unstructured":"20) Society CD: Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020 Edition). (Part 1). Chin J Pract Intern Med, 2021; 41: 668-695. [in Chinese]"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O and Group ESCSD: 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 2020; 41: 111-188","DOI":"10.15829\/1560-4071-2020-3826"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sturzebecher PE, Schorr JJ, Klebs SHG and Laufs U: Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses. Atherosclerosis, 2023; 367: 24-33","DOI":"10.1016\/j.atherosclerosis.2023.01.014"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Upadhyaya B, Wang Y, Bruckel J and Block RC: Frequency of lipoprotein(a) measurements in patients with or at risk of cardiovascular disease. J Clin Lipidol, 2023; 17: 743-747","DOI":"10.1016\/j.jacl.2023.09.009"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Mehta A, Jain V, Saeed A, Saseen JJ, Gulati M, Ballantyne CM and Virani SS: Lipoprotein(a) and ethnicities. Atherosclerosis, 2022; 349: 42-52","DOI":"10.1016\/j.atherosclerosis.2022.04.005"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Enkhmaa B and Berglund L: Non-genetic influences on lipoprotein(a) concentrations. Atherosclerosis, 2022; 349: 53-62","DOI":"10.1016\/j.atherosclerosis.2022.04.006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Mora S, Kamstrup PR, Rifai N, Nordestgaard BG, Buring JE and Ridker PM: Lipoprotein(a) and risk of type 2 diabetes. Clin Chem, 2010; 56: 1252-1260","DOI":"10.1373\/clinchem.2010.146779"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Paige E, Masconi KL, Tsimikas S, Kronenberg F, Santer P, Weger S, Willeit J, Kiechl S and Willeit P: Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature. Cardiovasc Diabetol, 2017; 16: 38","DOI":"10.1186\/s12933-017-0520-z"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Muhanhali D, Zhai T, Cai Z and Ling Y: Lipoprotein(a) concentration is associated with risk of type 2 diabetes and cardiovascular events in a Chinese population with very high cardiovascular risk. Endocrine, 2020; 69: 63-72","DOI":"10.1007\/s12020-020-02286-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ding L, Song A, Dai M, Xu M, Sun W, Xu B, Sun J, Wang T, Xu Y, Lu J, Wang W, Bi Y and Ning G: Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population. J Lipid Res, 2015; 56: 920-926","DOI":"10.1194\/jlr.P049015"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Littmann K, Hagstrom E, Habel H, Bottai M, Eriksson M, Parini P and Brinck J: Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up. Eur J Prev Cardiol, 2022; 28: 2038-2047","DOI":"10.1093\/eurjpc\/zwab016"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Cao YX, Zhang HW, Jin JL, Liu HH, Zhang Y, Zhang M, Gao Y, Guo YL, Wu NQ, Zhu CG, Dong Q, Sun J, Wang LF, Gao RL and Li JJ: Lipoprotein(a) and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: A Prospective Cohort Study. Thromb Haemost, 2021; 121: 1161-1168","DOI":"10.1055\/a-1340-2109"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Liu SL, Wu NQ, Guo YL, Zhu CG, Gao Y, Sun J, Xu RX, Liu G, Dong Q and Li JJ: Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort study. Postgrad Med J, 2019; 95: 534-540","DOI":"10.1136\/postgradmedj-2019-136591"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Liu HH, Cao YX, Jin JL, Zhang HW, Hua Q, Li YF, Guo YL, Zhu CG, Wu NQ, Xu RX, Chen XH and Li JJ: Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long-Term Follow-up Study on Real-World Patients Receiving Percutaneous Coronary Intervention. J Am Heart Assoc, 2020; 9: e014581","DOI":"10.1161\/JAHA.119.014581"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Xia J, Guo C, Liu K, Xie Y, Cao H, Peng W, Sun Y, Liu X, Li B and Zhang L: Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study. Lipids Health Dis, 2021; 20: 57","DOI":"10.1186\/s12944-021-01482-0"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Xia J, Guo C, Cao H, Liu K, Peng W, Sun Y, Xie Y, Li B, Zhang F, Wen F and Zhang L: Impact of lipoprotein(a) level on cardiometabolic disease in the Chinese population: The CHCN-BTH Study. Eur J Clin Invest, 2022; 52: e13689","DOI":"10.1111\/eci.13689"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Lin L, Deng KQ, Chen Z, Lei F, Qin JJ, Huang X, Sun T, Zhang X, Hu Y, Zhang P, Ji YX, Zhang XJ, She ZG, Lu Z, Cai J and Li H: Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population. Atherosclerosis, 2023; 372: 1-9","DOI":"10.1016\/j.atherosclerosis.2023.03.007"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Raitakari OT, Adams MR and Celermajer DS: Effect of Lp(a) on the early functional and structural changes of atherosclerosis. Arterioscler Thromb Vasc Biol, 1999; 19: 990-995","DOI":"10.1161\/01.ATV.19.4.990"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Sramek A, Reiber JH, Baak-Pablo R, Sturk A and Rosendaal FR: Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery. J Thromb Haemost, 2003; 1: 374-379","DOI":"10.1046\/j.1538-7836.2003.00064.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Steffen BT, Thanassoulis G, Duprez D, Stein JH, Karger AB, Tattersall MC, Kaufman JD, Guan W and Tsai MY: Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis. Arterioscler Thromb Vasc Biol, 2019; 39: 523-529","DOI":"10.1161\/ATVBAHA.118.312267"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Huffman MD, Kandula NR, Baldridge AS, Tsai MY, Prabhakaran D and Kanaya AM: Evaluating the Potential Association Between Lipoprotein(a) and Atherosclerosis (from the Mediators of Atherosclerosis Among South Asians Living in America Cohort). Am J Cardiol, 2019; 123: 919-921","DOI":"10.1016\/j.amjcard.2018.12.013"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) van Dam-Nolen DHK, van Dijk AC, Crombag G, Lucci C, Kooi ME, Hendrikse J, Nederkoorn PJ, Daemen M, van der Steen AFW, Koudstaal PJ, Kronenberg F, Roeters van Lennep JE, Mulder MT and van der Lugt A: Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK (PARISK) study. Atherosclerosis, 2021; 329: 22-29","DOI":"10.1016\/j.atherosclerosis.2021.06.004"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Xia S, Qiu W, Cai A, Kong B, Xu L, Wu Z and Li L: The association of lipoprotein(a) and intraplaque neovascularization in patients with carotid stenosis: a retrospective study. BMC Cardiovasc Disord, 2021; 21: 285","DOI":"10.1186\/s12872-021-02038-x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Zhou BY, Sun D, Wang C, Wu NQ, Guo YL, Zhu CG, Gao Y, Liu G, Dong Q and Li JJ: Plasma Lipoprotein(a) Concentration Is Associated With the Coronary Severity but Not With Events in Stable Coronary Artery Disease Patients: A Chinese Cohort Study. Heart Lung Circ, 2019; 28: 1009-1017","DOI":"10.1016\/j.hlc.2018.05.190"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Kaiser Y, Daghem M, Tzolos E, Meah MN, Doris MK, Moss AJ, Kwiecinski J, Kroon J, Nurmohamed NS, van der Harst P, Adamson PD, Williams MC, Dey D, Newby DE, Stroes ESG, Zheng KH and Dweck MR: Association of Lipoprotein(a) With Atherosclerotic Plaque Progression. J Am Coll Cardiol, 2022; 79: 223-233","DOI":"10.1016\/j.jacc.2021.10.044"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Huded CP, Shah NP, Puri R, Nicholls SJ, Wolski K, Nissen SE and Cho L: Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular Ultrasound. J Am Heart Assoc, 2020; 9: e018023","DOI":"10.1161\/JAHA.120.018023"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Kotani K, Yamada S, Yamada T, Kario K and Taniguchi N: Oxidized lipoprotein(a) and cardio-ankle vascular index (CAVI) in hypertensive subjects. Heart Vessels, 2013; 28: 461-466","DOI":"10.1007\/s00380-012-0265-2"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Wakabayashi I and Masuda H: Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus. Clin Chim Acta, 2006; 373: 127-131","DOI":"10.1016\/j.cca.2006.05.018"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Vallee A: Association Between Lipids and Arterial Stiffness for Primary Cardiovascular Prevention in a General Middle-Aged European Population. Front Cardiovasc Med, 2022; 9: 899841","DOI":"10.3389\/fcvm.2022.899841"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Simistiras A, Georgiopoulos G, Delialis D, Mavraganis G, Oikonomou E, Maneta E, Loutos C, Evangelou E and Stamatelopoulos K: Association of Lipoprotein(a) with arterial stiffness: A Mendelian randomization study. Eur J Clin Invest, 2024; e14168","DOI":"10.1111\/eci.14168"},{"key":"50","unstructured":"50) Hui H, Aihua Z, Jing C and LAingqing Y: Consensus and controversy on research progress and clinical practice of vascular calcification. Acta Physiologica Sinica, 2022; 74: 859-884"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Rosenson RS and Goonewardena SN: The Residual Risk Odyssey: From LDL to Lp(a). J Am Coll Cardiol, 2021; 78: 434-436","DOI":"10.1016\/j.jacc.2021.04.103"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Tsimikas S: A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. J Am Coll Cardiol, 2017; 69: 692-711","DOI":"10.1016\/j.jacc.2016.11.042"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/4\/32_65214\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:41:40Z","timestamp":1743828100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/4\/32_65214\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65214","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"article-number":"65214"}}